![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ABCB8 |
Gene summary for ABCB8 |
![]() |
Gene information | Species | Human | Gene symbol | ABCB8 | Gene ID | 11194 |
Gene name | ATP binding cassette subfamily B member 8 | |
Gene Alias | EST328128 | |
Cytomap | 7q36.1 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q9NUT2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11194 | ABCB8 | LZE2T | Human | Esophagus | ESCC | 1.53e-07 | 5.48e-01 | 0.082 |
11194 | ABCB8 | LZE7T | Human | Esophagus | ESCC | 4.39e-02 | 1.63e-01 | 0.0667 |
11194 | ABCB8 | LZE8T | Human | Esophagus | ESCC | 3.70e-03 | 1.76e-01 | 0.067 |
11194 | ABCB8 | LZE20T | Human | Esophagus | ESCC | 4.88e-02 | 1.17e-01 | 0.0662 |
11194 | ABCB8 | LZE24T | Human | Esophagus | ESCC | 3.12e-10 | 2.65e-01 | 0.0596 |
11194 | ABCB8 | P1T-E | Human | Esophagus | ESCC | 4.40e-04 | 2.09e-01 | 0.0875 |
11194 | ABCB8 | P2T-E | Human | Esophagus | ESCC | 2.06e-08 | 1.81e-01 | 0.1177 |
11194 | ABCB8 | P4T-E | Human | Esophagus | ESCC | 1.11e-14 | 3.38e-01 | 0.1323 |
11194 | ABCB8 | P5T-E | Human | Esophagus | ESCC | 3.52e-19 | 3.43e-01 | 0.1327 |
11194 | ABCB8 | P8T-E | Human | Esophagus | ESCC | 3.97e-04 | 1.13e-01 | 0.0889 |
11194 | ABCB8 | P9T-E | Human | Esophagus | ESCC | 7.05e-12 | 2.64e-01 | 0.1131 |
11194 | ABCB8 | P10T-E | Human | Esophagus | ESCC | 3.89e-12 | 1.97e-01 | 0.116 |
11194 | ABCB8 | P11T-E | Human | Esophagus | ESCC | 7.14e-08 | 3.36e-01 | 0.1426 |
11194 | ABCB8 | P12T-E | Human | Esophagus | ESCC | 1.77e-22 | 4.13e-01 | 0.1122 |
11194 | ABCB8 | P15T-E | Human | Esophagus | ESCC | 9.59e-25 | 5.30e-01 | 0.1149 |
11194 | ABCB8 | P16T-E | Human | Esophagus | ESCC | 1.18e-15 | 2.54e-01 | 0.1153 |
11194 | ABCB8 | P17T-E | Human | Esophagus | ESCC | 5.85e-12 | 3.74e-01 | 0.1278 |
11194 | ABCB8 | P19T-E | Human | Esophagus | ESCC | 1.11e-09 | 6.35e-01 | 0.1662 |
11194 | ABCB8 | P20T-E | Human | Esophagus | ESCC | 4.83e-06 | 1.89e-01 | 0.1124 |
11194 | ABCB8 | P21T-E | Human | Esophagus | ESCC | 2.49e-44 | 8.04e-01 | 0.1617 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa020102 | Liver | HCC | ABC transporters | 29/4020 | 45/8465 | 1.62e-02 | 3.88e-02 | 2.16e-02 | 29 |
hsa020103 | Liver | HCC | ABC transporters | 29/4020 | 45/8465 | 1.62e-02 | 3.88e-02 | 2.16e-02 | 29 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ABCB8 | SNV | Missense_Mutation | rs772895911 | c.1310G>A | p.Arg437Gln | p.R437Q | Q9NUT2 | protein_coding | deleterious(0.02) | probably_damaging(0.941) | TCGA-A2-A0CO-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | CR |
ABCB8 | SNV | Missense_Mutation | c.2064N>T | p.Trp688Cys | p.W688C | Q9NUT2 | protein_coding | tolerated(0.27) | benign(0) | TCGA-A7-A13F-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
ABCB8 | SNV | Missense_Mutation | rs374885136 | c.1100G>A | p.Arg367Gln | p.R367Q | Q9NUT2 | protein_coding | tolerated(0.14) | benign(0) | TCGA-AC-A5EH-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ABCB8 | SNV | Missense_Mutation | c.1735N>A | p.Glu579Lys | p.E579K | Q9NUT2 | protein_coding | tolerated(0.14) | benign(0.292) | TCGA-AR-A24Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
ABCB8 | SNV | Missense_Mutation | c.748C>A | p.Gln250Lys | p.Q250K | Q9NUT2 | protein_coding | tolerated(0.06) | benign(0.115) | TCGA-C8-A12T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ABCB8 | SNV | Missense_Mutation | novel | c.19C>G | p.Arg7Gly | p.R7G | Q9NUT2 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.995) | TCGA-C8-A8HP-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | 5-fluorouracil | CR |
ABCB8 | SNV | Missense_Mutation | rs142475735 | c.997G>A | p.Val333Ile | p.V333I | Q9NUT2 | protein_coding | tolerated(0.09) | possibly_damaging(0.692) | TCGA-D8-A1JT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
ABCB8 | SNV | Missense_Mutation | c.867N>T | p.Met289Ile | p.M289I | Q9NUT2 | protein_coding | tolerated(0.38) | benign(0.003) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ABCB8 | SNV | Missense_Mutation | rs756291701 | c.298G>A | p.Val100Ile | p.V100I | Q9NUT2 | protein_coding | tolerated_low_confidence(0.37) | benign(0.001) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ABCB8 | SNV | Missense_Mutation | novel | c.1539N>T | p.Lys513Asn | p.K513N | Q9NUT2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |